Pregnancy Registries: An Important Safety Strategy in the Risk Management Arena

Posted 01 November 2008 | By

The biopharmaceutical industry is continually seeking new and better ways to evaluate the risks and benefits of medicinal products and to create risk management interventions to protect the public's health. These new risk management initiatives are viewed as a priority in the industry and represent some of the most important events affecting drug safety in decades.

Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe